Opa interacting protein 5 acts as an oncogene in bladder cancer.

about

Lentivirus-mediated shRNA targeting inhibits malignant phenotypes of bladder cancer SW780 cells Identification of an eight-gene prognostic signature for lung adenocarcinoma

P2860

Q57071389-F403FA5C-8A3F-4034-9389-CEFC33583DF7 Q58754531-2CA532B9-4004-4571-9B4D-8300D3354FFB

P2860

Opa interacting protein 5 acts as an oncogene in bladder cancer.

Item

http://www.wikidata.org/entity/Q40116026

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Opa interacting protein 5 acts as an oncogene in bladder cancer.

@en

type

Item

label

Opa interacting protein 5 acts as an oncogene in bladder cancer.

@en

prefLabel

Opa interacting protein 5 acts as an oncogene in bladder cancer.

@en

P1476

Opa interacting protein 5 acts as an oncogene in bladder cancer

@en

P2093

Jianquan Hou

http://www.w3.org/2001/XMLSchema#string

Jigen Ping

http://www.w3.org/2001/XMLSchema#string

Jun He

http://www.w3.org/2001/XMLSchema#string

Xuefeng He

http://www.w3.org/2001/XMLSchema#string

P2860

LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit

Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth

Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1

Bladder Preservation for Muscle Invasive Bladder Cancer

Infection and cancer: global distribution and burden of diseases

Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity

Cancer statistics, 2012

Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses

Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

P2888

s00432-017-2485-4

P304

2221-2233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-017-2485-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

143

http://www.w3.org/2001/XMLSchema#string

P50

Duangai Wen

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28752236

http://www.w3.org/2001/XMLSchema#string

Opa interacting protein 5 acts as an oncogene in bladder cancer.

about

P2860

P2860

Opa interacting protein 5 acts as an oncogene in bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698